Your browser doesn't support javascript.
loading
Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification.
Matzkin, Haim; Chen, Juza; Agai, Rubi; Ziv-Baran, Tomer; Mabjeesh, Nicola J.
Afiliação
  • Matzkin H; Department of Urology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Chen J; Department of Urology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Agai R; The Institute of Radiotherapy, Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Ziv-Baran T; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Mabjeesh NJ; Department of Urology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
PLoS One ; 14(4): e0215582, 2019.
Article em En | MEDLINE | ID: mdl-31002732
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia / Radioterapia de Intensidade Modulada / Antagonistas de Androgênios Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia / Radioterapia de Intensidade Modulada / Antagonistas de Androgênios Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article